PAVIA will utilize a ‘triangle model’ involving a formalised and intense collaboration between a trio of actors/stakeholders relevant to PV for a specific PRD at country level.

1.the National Medicines Regulatory Authority including the national PV Centre

2.the Public Health Programme/NTP and health facilities responsible for treatment delivery

3.the clinical experts employed by a Medical Research Institute

The PAVIA triangle model

The PAVIA consortium consists of partners from Europe and Africa

The European partners are:

Amsterdam Institute of Global Health, Amsterdam, the Netherlands

Netherlands Pharmacovigilance Centre Lareb, Den Bosch, the Netherlands

KNCV Tuberculosis Foundation, The Hague, the Netherlands

University of Verona, Italy

The African partner are from four different countries which are the following:

Tanzania

Kilimanjaro Clinical Research Institute, Moshi, Tanzania

Tanzania Medicines and Medical Devices Authority (TMDA), Dar es Salaam, Tanzania

Ethiopia

Armhauer Hansen Research Institute (AHRI), Addis Abeba, Ethiopia

Ministry of Health, Ethiopia

Food, Medicine, and Health Care Administration and Control Authority of Ethiopia

Nigeria

Institute of Human Virology Nigeria (IHVN), Nigeria

University of Benin, Nigeria

National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria

eSwatini

Management of Sciences for Health, Swaziland

Ministry of Health, Swaziland